Insulin Peglispro

DRUG8 trials

Sponsors

Eli Lilly and Company

Conditions

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Healthy VolunteersType 2 Diabetes Mellitus

Phase 1

A Study of Insulin Peglispro and Glargine on Fats in Participants With Type 1 Diabetes

CompletedNCT01771250

Eli Lilly and CompanyDiabetes Mellitus, Type 1

Start: 2013-10-31End: 2014-12-31Updated: 2019-03-11

A Study of Insulin Peglispro in Healthy Male Japanese Participants

CompletedNCT01995526

Eli Lilly and CompanyHealthy Volunteers

Start: 2013-12-31End: 2014-01-31Updated: 2018-10-19

A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fat Tissue

CompletedNCT02109029

Eli Lilly and CompanyDiabetes Mellitus, Type 1

Start: 2014-04-30End: 2015-03-31Updated: 2019-03-06

A Study to Compare and Measure the Effects of Insulin Peglispro (LY2605541) and Glargine on Meal Time Insulin Requirements

CompletedNCT02152384

Eli Lilly and CompanyDiabetes Mellitus, Type 1

Start: 2014-06-30End: 2014-12-31Updated: 2019-03-01

A Study To Compare the Effects of Insulin Peglispro and Glargine on Insulin Sensitivity and Meal Time Insulin Requirements in Type 2 Diabetics

CompletedNCT02197520

Eli Lilly and CompanyDiabetes Mellitus, Type 2

Start: 2014-07-31End: 2015-06-30Updated: 2018-11-01

Phase 3

A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin Treatment

CompletedNCT01894568

Eli Lilly and CompanyType 2 Diabetes Mellitus

Start: 2013-07-31End: 2015-04-30Updated: 2019-03-15

A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus

WithdrawnNCT02106364

Eli Lilly and CompanyDiabetes Mellitus, Type 2

Start: 2015-02-28End: 2016-06-30Updated: 2016-03-28

A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 Diabetes

CompletedNCT02132637

Eli Lilly and CompanyType 2 Diabetes Mellitus

Start: 2014-05-31End: 2015-07-31Updated: 2019-09-18